Cancer/Radiotherapie

Aims & Scope

Cancer/radiothérapie se veut d'abord et avant tout un organe francophone de publication des travaux de recherche en radiothérapie.

La revue a pour objectif de diffuser les informations majeures sur les travaux de recherche en cancérologie et tout ce qui touche de près ou de loin au traitement du cancer par les radiations : technologie, radiophysique, radiobiologie et radiothérapie clinique.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.4
2024	1.50

Journal Rank

Year	Value
2024	12644

Journal Citation Indicator

Year	Value
2024	565

SJR (SCImago Journal Rank)

Year	Value
2024	0.450

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	39

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83)

  Citation: 233

  Authors: V., T.R.

• Définition des volumes en radiothérapie externe : rapports ICRU 50 et 62

  Citation: 107

  Authors: J., A.

• Clinical application of image-guided radiotherapy, IGRT (on the Varian OBI platform)

  Citation: 97

  Authors: Bruno, Aris

• Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993–1997) compared to the preceding period in the context of ICRU 38 recommendations

  Citation: 96

  Authors: R., T.H., C., M., A., H.

• Délinéation des organes à risque et contraintes dosimétriques

  Citation: 90

  Authors: G., D., I., B.

• Reduction of organ motion effects in IMRT and conformal 3D radiation delivery by using gating and tracking techniques

  Citation: 90

  Authors: P., E., S., L., K., G.

• Radiotherapy of cervical cancer

  Citation: 88

  Authors: C., K., A., S., C., A., D., C., C.

• Early side effects of radiation treatment for head and neck cancer

  Citation: 83

  Authors: I.

• The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 “boost versus no boost” trial

  Citation: 81

  Authors: P.M., L., H., H., W.F., A., J.J., W., R.-P., J.-B., M., M., C.C., M., J.-C.

• Mécanismes moléculaires contrôlant le cycle cellulaire : aspects fondamentaux et implications en cancérologie

  Citation: 68

  Authors: J.F., F., F., J.L., J.

---